QuantClaw Research Model Portfolio

European Bottleneck Champions

Own the scarce European suppliers behind AI datacenters, semiconductors, pharma bioprocessing, power infrastructure, and frontier defense, with a 25% systematic hedge.

Monthly rebalance75% long core25% short hedgeEurope listedBottleneck moats

Concept: not another generic AI basket. This strategy targets the invisible supply-chain choke points, companies with ASML-like or oligopoly economics where qualification cycles, installed base, process know-how, and regulatory requirements create durable moats.

Long core, 75%

AI power, cooling, electrification

SU.PA Schneider10%

PRY.MI Prysmian7%

MTRS.ST Munters5%

Datacenter power, cables, thermal bottlenecks.

Semicap, photonics, precision

ASML.AS ASML8%

ASM.AS ASM Int.7%

VACN.SW VAT Group5%

BESI.AS BESI4%

True or near-true bottlenecks in chip equipment and vacuum/packaging.

Pharma, gases, frontier defense

LONN.SW Lonza9%

DIM.PA Sartorius Stedim6%

AI.PA Air Liquide8%

HO.PA Thales6%

Bioprocessing, specialty gases, defense electronics, cyber and space.

Short hedge, 25%

STOXX Europe 600 / broad EU equity hedge
Primary implementation via liquid index/ETF/CFD where available.-15%

Overvalued non-bottleneck Europe tech basket
Screened monthly: high valuation, weak moat, negative revisions, no supply-chain bottleneck.-10%

Hedge purpose

Keep the product long structural scarcity while reducing market beta, rate shock, and Europe-wide risk. The short sleeve is a hedge, not a “losers” marketing message.

Monthly rebalance logic

Score each company monthly from 0-100:

30% moat / bottleneck power20% frontier exposure20% valuation15% earnings revisions10% balance sheet5% momentum

Hold 10-14 long names. Max single long 10%. Trim if valuation enters top decile without matching revision support. Add when bottleneck score remains high and price/valuation derates. Re-check short hedge monthly and after major macro/earnings shocks.

Best deeper-work candidates

Lonza

Biologics/CDMO bottleneck. Pharma capacity and regulatory switching costs.

Thales

Defense electronics, cyber, space. Frontier/national-security exposure at reasonable valuation.

Air Liquide

Specialty gases for semis, pharma and hydrogen. Quality compounder.

Prysmian

Cable/grid bottleneck for electrification and datacenters.

Schneider

Premium datacenter power infrastructure winner.

VAT / ASM / BESI

Watchlist: highly strategic, but valuation-sensitive.

Create this in Tori / Agent Portfolio

Copy this prompt into Tori or any agent connected to your eToro account. It asks for a paper/model portfolio first, not live execution.

Create a paper/model Agent Portfolio called European Bottleneck Champions.

Objective: own European public-market bottleneck suppliers behind AI datacenters, semiconductors, pharma bioprocessing, power infrastructure, specialty gases/materials, and frontier defense, with a 25% hedge.

Portfolio structure:
- 75% long core
- 25% short hedge
- Monthly rebalance
- Research/model only unless I explicitly approve live execution

Long core weights:
- Schneider Electric (SU.PA) 10%
- Prysmian (PRY.MI) 7%
- Munters (MTRS.ST) 5%
- ASML (ASML.AS) 8%
- ASM International (ASM.AS) 7%
- VAT Group (VACN.SW) 5%
- BESI (BESI.AS) 4%
- Lonza (LONN.SW) 9%
- Sartorius Stedim (DIM.PA) 6%
- Air Liquide (AI.PA) 8%
- Thales (HO.PA) 6%

Short hedge:
- 15% broad Europe equity hedge, preferably STOXX Europe 600 liquid ETF/CFD if available
- 10% overvalued non-bottleneck Europe tech basket, selected mechanically by weak moat, high valuation, negative revisions

Monthly scoring model:
- 30% moat / bottleneck power
- 20% frontier exposure
- 20% valuation
- 15% earnings revisions
- 10% balance sheet
- 5% momentum

Rules:
- Keep 10-14 long names, max single long 10%
- Maintain gross around 100% and net around 50% after hedge, unless platform rules require long-only
- Include transaction costs, FX, dividends, and short financing assumptions where possible
- Label any backtest using current constituents as biased/exploratory unless point-in-time data is used
- Do not execute live trades without explicit confirmation

Explain the resulting portfolio, risks, and required approvals before creating or trading.

3Y exploratory backtest

THIS USES BIASED DATA. Current constituents were applied retroactively, so this is exploratory/demo only, not decision-grade.

Strategy total return
+41.5%
CAGR 12.1%, vol 13.7%, Sharpe 0.89

Max drawdown
-15.9%
Monthly rebalance, 10 bps turnover cost

Benchmark proxy
+43.9%
EXSA.DE STOXX Europe 600 proxy, CAGR 12.7%

Run log: bottleneck_biased_3y_20260521111602. Missing for decision-grade: PIT universe, PIT fundamentals/revisions, borrow costs, full FX/dividend validation.

Optimized exploratory variant

THIS ALSO USES BIASED DATA. I ran a CPU grid-search of variants, not GPU, because this host has no verified GPU. Best risk-adjusted variant was simple: remove the short hedge and equal-weight the bottleneck long book.

Best Sharpe variant
Equal-weight, 0% hedge
Total +91.7%, CAGR 23.9%, Sharpe 1.04, DD -27.0%

Highest return variant
Equal-weight + momentum, 0% hedge
Total +136.1%, CAGR 32.7%, Sharpe 0.94, DD -43.6%

Benchmark proxy
+43.9%
STOXX Europe 600 proxy, CAGR 12.7%, Sharpe 0.99

Finding: the hedge protected less than it cost during this 3Y bull phase. For a marketable version, show the equal-weight long-only optimized exploratory variant, and keep the 25% hedge as an optional defensive overlay rather than default.

Backtest status

Decision-grade 3-year backtest is pending point-in-time data.

To avoid look-ahead bias, the backtest must use historical European tradable-universe snapshots, lagged fundamentals, historical analyst revisions, corporate actions, FX, dividends, transaction costs, and short/borrow assumptions available at each monthly rebalance date.

Planned monthly simulation:

Freeze eligible universe each monthLag fundamentals 45-60 daysRank by 0-100 bottleneck scoreLong top 10-1425% mechanical hedge

A current-basket 3-year chart can be produced quickly, but it would be explicitly biased because today’s constituents and today’s moat knowledge would be applied retroactively. This page will show performance results only after the PIT dataset is available or after explicit approval to publish an exploratory biased-data demo.